Avioq Announces CE Mark and European Launch of VioOne HIV Profile Supplemental Assay
Avioq, Inc. has received CE Marking (Conformité Européenne ) and has begun marketing their Vio One™ HIV Profile™ Supplemental Assay in the European Union and other CE Mark countries.
The product has also been submitted for FDA approval. “We are pleased to provide the CE Mark HIV Profile™ assay to countries outside the U.S.,” said Chamroen Chetty, CEO of Avioq. Dr. Chetty continues, “We are also looking for distribution partners to expand the global availability.”
The HIV Profile™ is an enzyme-linked immunosorbent assay (ELISA) for confirmation and differentiation of individual antibodies directed to various gene products of HIV-1 (Group M & Group O) and HIV-2 in human serum or plasma that were repeatedly reactive in diagnostic screening procedures. Results can also be used to distinguish recent from longstanding HIV-1 infection for HIV-1 incidence estimation.
About Confirmatory Testing
In 2014, the CDC released a new algorithm for HIV testing. The second step of the algorithm includes a supplemental assay that can detect and differentiate HIV-1 and HIV-2 for confirmation of repeatedly reactive HIV-1/HIV-2 screening results. Historically in the USA, this has been done using an FDA approved Western Blot or IFA assay. The HIV Profile™ assay is an improved, faster and easier alternative with performance that aligns with the algorithm.
Avioq, Inc., located in Research Triangle Park, North Carolina, is a medical device company established to develop and market high-quality immunodiagnostic products. Avioq is committed to working closely with its customers to meet their needs and provide the highest quality service. For more information about the Vio One™ HIV Profile™ Supplemental Assay, visit www.avioq.com .
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
WA-FLUKE-CORPORATION19.7.2019 12:02:10 CEST | Press release
Fluke Corporation Acquires Industrial Reliability Leader PRÜFTECHNIK
JANSSEN19.7.2019 12:01:09 CEST | Press release
Janssen Seeks EMA Approval for Novel Subcutaneous Formulation of DARZALEX®▼ (daratumumab)
SARTORIUS19.7.2019 07:02:05 CEST | Press release
Business Figures for the First Half of 2019: Sartorius Continues Double-digit Growth
CA-QUANERGY-SYSTEMS18.7.2019 21:02:06 CEST | Press release
Quanergy and Chery Established Partnership to Propel a New Era of Autonomous Vehicles and Smart Cities
LARSEN-&-TOUBRO-INFOTECH18.7.2019 18:10:08 CEST | Press release
LTI USD Revenue Growth up 11.5% YoY; Digital Revenues at 39%
NY-MOODY’S-ANALYTICS18.7.2019 17:32:06 CEST | Press release
Moody’s Analytics Wins Wholesale Modelling Software of the Year at Risk Technology Awards
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom